|
1
|
Zang CB, Wächter M, Liu H, et al: Ligands
for PPARgamma and RAR cause induction of growth inhibition and
apoptosis in human glioblastomas. J Neurooncol. 65:107–118. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tang K, Cao L, Fan SQ, et al: Effect of
all-trans-retinoic acid on C6 glioma cell proliferation and
differentiation. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 33:892–897.
2008.(In Chinese).
|
|
3
|
Karsy M, Albert L, Tobias ME, Murali R and
Jhanwar-Uniyal M: All-trans retinoic acid modulates cancer stem
cells of glioblastoma multiforme in an MAPK-dependent manner.
Anticancer Res. 30:4915–4920. 2010.PubMed/NCBI
|
|
4
|
Campos B, Wan F, Farhadi M, et al:
Differentiation therapy exerts antitumor effects on stem-like
glioma cells. Clin Cancer Res. 16:2715–2728. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chang Q, Chen Z, You J, et al:
All-trans-retinoic acid induces cell growth arrest in a human
medulloblastoma cell line. J Neurooncol. 84:263–267. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li S, Gao Y, Pu K, Ma L, Song X and Liu Y:
All-trans retinoic acid enhances bystander effect of suicide-gene
therapy against medulloblastomas. Neurosci Lett. 503:115–119. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Das A, Banik NL and Ray SK: Molecular
mechanisms of the combination of retinoid and interferon-gamma for
inducing differentiation and increasing apoptosis in human
glioblastoma T98G and U87MG Cells. Neurochem Res. 34:87–101. 2009.
View Article : Google Scholar
|
|
8
|
Haque A, Banik NL and Ray SK: Emerging
role of combination of all-trans retinoic acid and interferon-gamma
as chemoimmunotherapy in the management of human glioblastoma.
Neurochem Res. 32:2203–2209. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang R, Banik NL and Ray SK: Combination
of all-trans retinoic acid and interferon-gamma upregulated
p27(kip1) and down regulated CDK2 to cause cell cycle arrest
leading to differentiation and apoptosis in human glioblastoma LN18
(PTEN-proficient) and U87MG (PTEN-deficient) cells. Cancer
Chemother Pharmacol. 62:407–416. 2008. View Article : Google Scholar
|
|
10
|
Karmakar S, Banik NL, Patel SJ and Ray SK:
Combination of all-trans retinoic acid and taxol regressed
glioblastoma T98G xenografts in nude mice. Apoptosis. 12:2077–2087.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Karmakar S, Banik NL and Ray SK:
Combination of all-trans retinoic acid and paclitaxel-induced
differentiation and apoptosis in human glioblastoma U87MG
xenografts in nude mice. Cancer. 112:596–607. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Distler JH, Hirth A, Kurowska-Stolarska M,
Gay RE, Gay S and Distler O: Angiogenic and angiostatic factors in
the molecular control of angiogenesis. Q J Nucl Med. 47:149–161.
2003.PubMed/NCBI
|
|
13
|
Folkman J and Klagsbrun M: Angiogenic
factors. Science. 235:442–447. 1987. View Article : Google Scholar
|
|
14
|
Muramatsu R, Takahashi C, Miyake S,
Fujimura H, Mochizuki H and Yamashita T: Angiogenesis induced by
CNS inflammation promotes neuronal remodeling through
vessel-derived prostacyclin. Nat Med. 18:1658–1664. 2012.
View Article : Google Scholar
|
|
15
|
Crawford TN, Alfaro DV III, Kerrison JB
and Jablon EP: Diabetic retinopathy and angiogenesis. Curr Diabetes
Rev. 5:8–13. 2009. View Article : Google Scholar
|
|
16
|
Würdinger T and Tannous BA: Glioma
angiogenesis: Towards novel RNA therapeutics. Cell Adh Migr.
3:230–235. 2009.PubMed/NCBI
|
|
17
|
Chen H, Fan K, Wang S, Liu Z and Zheng Z:
Dual targeting of glioma U251 cells with nanoparticles prevents
tumor angiogenesis and inhibits tumor growth. Curr Neurovasc Res.
9:133–138. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guo SW, Che HM and Li WZ: Anti-tumor
effect of lentivirus-mediated gene transfer of alphastatin on human
glioma. Cancer Sci. 102:1038–1044. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vredenburgh JJ, Desjardins A, Herndon JE
II, et al: Phase II trial of bevacizumab and irinotecan in
recurrent malignant glioma. Clin Cancer Res. 13:1253–1259. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kreisl TN, Kim L, Moore K, et al: Phase II
trial of single-agent bevacizumab followed by bevacizumab plus
irinotecan at tumor progression in recurrent glioblastoma. J Clin
Oncol. 27:740–745. 2009. View Article : Google Scholar
|
|
21
|
Plate KH, Breier G, Weich HA, Mennel HD
and Risau W: Vascular endothelial growth factor and glioma
angiogenesis: coordinate induction of VEGF receptors, distribution
of VEGF protein and possible in vivo regulatory mechanisms. Int J
Cancer. 59:520–529. 1994. View Article : Google Scholar
|
|
22
|
Bodey B, Siegel SE and Kaiser HE:
Up-regulation of VEGF expression and related neo-angiogenesis in
childhood high-grade gliomas: implications for anti-angiogenic
anti-neoplastic therapy. In Vivo. 20:511–518. 2006.PubMed/NCBI
|
|
23
|
Zagzag D, Lukyanov Y, Lan L, et al:
Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in
glioblastoma: implications for angiogenesis and glioma cell
invasion. Lab Invest. 86:1221–1232. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li D, Li XP, Wang HX, et al: VEGF induces
angiogenesis in a zebrafish embryo glioma model established by
transplantation of human glioma cells. Oncol Rep. 28:937–942.
2012.PubMed/NCBI
|
|
25
|
Carmeliet P, Dor Y, Herbert JM, et al:
Role of HIF-1alpha in hypoxia-mediated apoptosis, cell
proliferation and tumour angiogenesis. Nature. 394:485–490. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Conway EM, Collen D and Carmeliet P:
Molecular mechanisms of blood vessel growth. Cardiovasc Res.
49:507–521. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
|
|
28
|
Weidner N, Semple JP, Welch WR and Folkman
J: Tumor angiogenesis and metastasis - correlation in invasive
breast carcinoma. N Engl J Med. 324:1–8. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang JP, Chen XY and Li JS: Effects of
all-trans-retinoic on human gastric cancer cells BGC-823. J Dig
Dis. 8:29–34. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lu TY, Li WC, Chen RY, et al: Inhibition
effects of all trans-retinoic acid on the growth and angiogenesis
of esophageal squamous cell carcinoma in nude mice. Chin Med J
(Engl). 124:2708–2714. 2011.PubMed/NCBI
|
|
31
|
Tee MK, Vigne JL and Taylor RN: All-trans
retinoic acid inhibits vascular endothelial growth factor
expression in a cell model of neutrophil activation. Endocrinology.
147:1264–1270. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Saito A, Sugawara A, Uruno A, et al:
All-trans retinoic acid induces in vitro angiogenesis via retinoic
acid receptor: possible involvement of paracrine effects of
endogenous vascular endothelial growth factor signaling.
Endocrinology. 148:1412–1423. 2007. View Article : Google Scholar
|
|
33
|
Chen JT, Liang JB, Chou CL, Shyu RC and Lu
DW: Retinoic acid induces VEGF gene expression in human retinal
pigment epithelial cells (ARPE-19). J Ocul Pharmacol Ther.
21:413–419. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Akiyama H, Tanaka T, Maeno T, et al:
Induction of VEGF gene expression by retinoic acid through
Sp1-binding sites in retinoblastoma Y79 cells. Invest Ophthalmol
Vis Sci. 43:1367–1374. 2002.PubMed/NCBI
|
|
35
|
Wang C, Chen FY, Gu CH, et al: Effect of
ATRA and DNR on the expression and secretion of VEGF in leukemic
cells. Zhonghua Xue Ye Xue Za Zhi. 25:171–174. 2004.(In
Chinese).
|
|
36
|
Ye J, Liu FQ and Wu YP: The effect of
all-trans retinoid acid and sodium selenite
(Na2SeO3) on VEGF and its receptor expression
in HL-60 cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 12:142–146.
2004.(In Chinese).
|
|
37
|
Bai X, Fu JX, Ding KY, Cen JN, Wang W and
Ruan CG: Quantitative analysis of gene expression for vascular
endothelial growth factor and its application. Zhongguo Shi Yan Xue
Ye Xue Za Zhi. 13:548–552. 2005.(In Chinese).
|
|
38
|
Cho DH, Choi YJ, Jo SA, Nam JH, Jung SC
and Jo I: Retinoic acid decreases nitric oxide production in
endothelial cells: a role of phosphorylation of endothelial nitric
oxide synthase at Ser(1179). Biochem Biophys Res Commun.
326:703–710. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Fernández-Martinez AB, Jiménez MI,
Hernández IS, et al: Mutual regulation of hypoxic and retinoic acid
related signalling in tubular proximal cells. Int J Biochem Cell
Biol. 43:1198–1207. 2011.PubMed/NCBI
|
|
40
|
Fernández-Martinez AB, Arenas Jiménez MI
and Lucio Cazaña FJ: Retinoic acid increases hypoxia-inducible
factor-α through intracrine prostaglandin E(2) signaling in human
renal proximal tubular cells HK-2. Biochim Biophys Acta.
1821:672–683. 2012.
|
|
41
|
Ardyanto TD, Osaki M, Tokuyasu N, Nagahama
Y and Ito H: CoCl2-induced HIF-1 alpha expression
correlates with proliferation and apoptosis in MKN-1 cells: A
possible role for the PI3K/Akt pathway. Int J Oncol. 29:549–555.
2006.PubMed/NCBI
|
|
42
|
Chattopadhyay N, Butters RR and Brown EM:
Agonists of the retinoic acid- and retinoid X-receptors inhibit
hepatocyte growth factor secretion and expression in U87 human
astrocytoma cells. Brain Res Mol Brain Res. 87:100–108. 2001.
View Article : Google Scholar : PubMed/NCBI
|
